Skip to main content
UniHealth

Doctor search

Charles Debattista, MD

Psychiatry · Palo Alto

NPI 1982749941

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
4
1 carrier
Offices
2

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

4 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Debattista’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026

California Medical Board record

Licence G69043 · Current

Licensed to practise in California · since 1990 · expires 2027-11-30 · University of California San Francisco School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$48,314

Medicare paid this office $48,314 for 66 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management30$18,264$118
Return visit (30+ min)29$12,306$116

Who their Medicare patients are

66 Original Medicare patients in 2024. Average age 68 · Under 65 24% · Women 53% · Also on Medicaid 21% · Health risk score 1.24. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.

Conditions among them: Depression 75% · High blood pressure 58% · Diabetes 27% · Coronary heart disease 17%.

The office billed $444,219, Medicare allowed $62,151 and paid $48,314; for 541 services of 8 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202466541681.24$444,219$48,314
202352429681.52$253,751$44,441
202254383671.47$205,812$31,493
202153447651.35$234,318$37,425
202055481661.22$256,529$36,645
201959392651.05$202,000$27,623
201870335631.17$79,690$13,456
201760249621.03$64,892$11,265
201639159610.93$30,430$8,458
201539138580.94$24,222$8,556
201436167571.05$25,860$9,203
201365233611.42$68,341$13,317

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Original Medicare services billed in 2023
Return visit (30+ min)26$11,172$120
Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management13$7,670$122
Long return visit (40+ min)14$3,836$174
Psychotherapy with evaluation and management visit, 30 minutes19$3,686$61
Telehealth originating site facility fee38$2,559$22

2022: 5 services

Original Medicare services billed in 2022
Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management16$11,353$120
Return visit (30+ min)27$10,871$117
Telehealth originating site facility fee40$2,594$20
Short return visit (20+ min)18$1,885$72
Psychotherapy with evaluation and management visit, 30 minutes17$1,503$63

2021: 4 services

Original Medicare services billed in 2021
Return visit (30+ min)34$14,332$119
Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management18$13,221$122
Psychotherapy with evaluation and management visit, 30 minutes20$4,427$62
Telehealth originating site facility fee36$2,718$21

2020: 5 services

Original Medicare services billed in 2020
Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management20$15,555$116
Return visit (30+ min)30$8,065$97
Psychotherapy with evaluation and management visit, 30 minutes28$5,240$63
Short return visit (20+ min)20$3,557$71
Telehealth originating site facility fee35$2,517$21

2019: 7 services

Original Medicare services billed in 2019
Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management18$12,229$116
Short return visit (20+ min)22$3,937$72
Psychotherapy with evaluation and management visit, 30 minutes11$2,012$63
Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management19$1,902$21
Psychotherapy with evaluation and management visit, 30 minutes14$1,544$51
Short return visit (20+ min)18$1,300$39
Return visit (30+ min)12$1,287$72

2018: 4 services

Original Medicare services billed in 2018
Short return visit (20+ min)29$4,700$44
Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management27$3,099$22
Psychotherapy with evaluation and management visit, 30 minutes22$2,637$56
Return visit (30+ min)19$1,554$62

2017: 4 services

Original Medicare services billed in 2017
Return visit (30+ min)22$5,149$68
Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management27$2,254$22
Psychotherapy with evaluation and management visit, 30 minutes12$1,521$56
Short return visit (20+ min)16$1,278$41

2016: 2 services

Original Medicare services billed in 2016
Return visit (30+ min)21$2,883$69
Short return visit (20+ min)22$2,829$43

2015: 2 services

Original Medicare services billed in 2015
Return visit (30+ min)28$6,036$69
Short return visit (20+ min)22$1,614$38

2014: 2 services

Original Medicare services billed in 2014
Short return visit (20+ min)25$4,140$43
Return visit (30+ min)20$3,381$64

2013: 4 services

Original Medicare services billed in 2013
Return visit (30+ min)22$3,959$54
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes31$3,708$63
Therapy using electrical currents12$3,423$86
Short return visit (20+ min)21$1,675$33

Money from drug and device companies

$7,964 in 2022

Industry payments by year
2022213$6,500$7,964
202011$585$585
2019418$13,930$17,600

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AbbvieVraylar$6,180
11 payments
  • Consulting for Vraylar · 2022-07-12 · $5,000
  • Meals for Vraylar · 2022-07-12 · $31
  • Travel for Vraylar · 2022-07-12 · $72
  • Meals for Vraylar · 2022-03-29 · $47
  • Meals for Vraylar · 2022-03-29 · $47
  • Meals for Vraylar · 2022-03-29 · $13
  • Travel for Vraylar · 2022-03-29 · $398
  • Travel for Vraylar · 2022-03-29 · $156
  • Meals for Vraylar · 2022-03-29 · $13
  • Travel for Vraylar · 2022-03-28 · $247
  • Travel for Vraylar · 2022-03-28 · $156
Almatica PharmaLoreev Xr$1,784
2 payments
  • Consulting for Loreev Xr · 2022-10-14 · $1,500
  • Meals for Loreev Xr · 2022-09-16 · $284
See all 13 published payments
Every published payment
Almatica PharmaConsulting · 2022-10-14Loreev Xr$1,500
Almatica PharmaMeals · 2022-09-16Loreev Xr$284
AbbvieConsulting · 2022-07-12Vraylar$5,000
AbbvieMeals · 2022-07-12Vraylar$31
AbbvieTravel · 2022-07-12Vraylar$72
AbbvieMeals · 2022-03-29Vraylar$47
AbbvieMeals · 2022-03-29Vraylar$47
AbbvieMeals · 2022-03-29Vraylar$13
AbbvieTravel · 2022-03-29Vraylar$398
AbbvieTravel · 2022-03-29Vraylar$156
AbbvieMeals · 2022-03-29Vraylar$13
AbbvieTravel · 2022-03-28Vraylar$247
AbbvieTravel · 2022-03-28Vraylar$156
See earlier years (2020, 2019)

2020: $585

Payments by company in 2020
Sage TherapeuticsNone$585
1 payment
  • Consulting · 2020-08-10 · $585

2019: $17,600

Payments by company in 2019
Sage TherapeuticsNone$9,154
7 payments
  • Consulting · 2019-12-12 · $6,630
  • Meals · 2019-12-12 · $43
  • Meals · 2019-12-12 · $43
  • Travel · 2019-12-12 · $1,895
  • Travel · 2019-12-12 · $299
  • Travel · 2019-12-12 · $179
  • Meals · 2019-12-11 · $66
AlkermesNone$7,927
5 payments
  • Consulting · 2019-06-17 · $6,800
  • Travel · 2019-05-07 · $129
  • Travel · 2019-05-03 · $296
  • Meals · 2019-05-03 · $166
  • Travel · 2019-05-03 · $536
Corcept TherapeuticsKorlym$500
1 payment
  • Consulting for Korlym · 2019-02-01 · $500
Johnson & Johnson Health Care SystemsSpravato$19
1 payment
  • Meals for Spravato · 2019-10-29 · $19

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Sage Therapeutics, Inc. · A Comparative Study of Sage-217 Plus Sertraline Versus Placebo Plus Sertraline in Adults With Major Depressive Disorder · 2022Their institution$12,893
Sage Therapeutics, Inc. · A Phase 3, Open-Label, 1-Year Study of the Safety, Tolerability, and Need for Re-Treatment With Sage-217 in Adult Subjects With Major Depressive Disorder · 2024Their institution$3,840

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1982749941
Licence
CA G69043California G69043: Current · expires 2027-11-30
Trained
University of California, San Francisco School of Medicine, 1989
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
Yes
Medicaid ID
CA 00G690430
Taxonomy
Psychiatry (2084P0800X)
Mailing address
300 Pasteur Dr, Palo Alto, CA, 94304
NPI first listed
2007-02-20
NPI last updated
2024-04-29
NPI record certified
2024-04-29

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 401 Quarry Rd, Palo Alto, CA, 94304